Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma is a research paper published in New England Journal of Medicine (2022). On theSindex it has a DataRank of 3.7. It has been cited 170 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.771
From this paper's citation signal
Citation Network Contribution
2.9
From 79 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Cancer Institute
Grant: U10CA180886; U10CA098543, U10CA180886
NCI NIH HHS
Grant: U24 CA180803
NCI NIH HHS
Grant: U10 CA029511
NCI NIH HHS
Grant: U10 CA098413
NCI NIH HHS
Grant: U10 CA098543
NCI NIH HHS
Grant: U10 CA180899
NCI NIH HHS
Grant: U10 CA180886
National Institutes of Health
Grant: 3U24CA180803-06S1
Imaging and Radiation Oncology Core (IROC) Group
National Institutes of Health
Grant: 5U10CA029511-14
QUALITY ASSURANCE REVIEW CENTER (QARC)
National Institutes of Health
Grant: 2U10CA180899-06
Children's Oncology Group Statistics and Data Center
National Institutes of Health
Grant: 3U10CA180886-01S1
COG NCTN Network Group Operations Center
National Institutes of Health
Grant: 3U10CA098543-03S1
Childrens Oncology Group Chairs Grant
Leukemia Lymphoma Society
St. Baldrick’s Foundation
FWCI
19.49
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals